Literature DB >> 10952038

High density insulin receptor-positive diabetogenic T lymphocytes in nonobese diabetic mice are memory cells.

J C Flynn1, M F McInerney.   

Abstract

Our previous work examining the importance of insulin receptor (IR) expression on T cells has demonstrated that when T cells from nonobese diabetic mice were sorted into populations expressing a high (IR(High)) and a low (IR(Low)) density of IR, IR(High) T cells rapidly transferred insulitis and diabetes. We have further characterized IR(High) T cells. Both CD4+ and CD8+ cells were detected in the IR(High) T cell population, but IR(High) expression was detected predominantly on CD4+ cells. IRHigh T cells were polyclonal for TCR Vbeta-chain expression. By 3 color flow cytometric analysis, virtually all IR(High) T cells expressed low or negligible levels of CD62L (CD62L(Low)/-) and high levels of CD44 (CD44(High)). The lack of IL-2 receptor and transferrin receptor expression as seen previously, together with the CD62L(Low)/- CD44(High) phenotype suggests that IR(High) T cells are memory cells. However, since only about one quarter of all of the CD62L(Low)/- or CD44(High) T cells were also IR(High), the IR(High) phenotype defines a subpopulation of memory T cells that are aggressively diabetogenic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952038     DOI: 10.3109/08923970009016427

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  2 in total

1.  IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells.

Authors:  Cristina Penaranda; Wilson Kuswanto; Jerry Hofmann; Rupert Kenefeck; Parth Narendran; Lucy S K Walker; Jeffrey A Bluestone; Abul K Abbas; Hans Dooms
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

2.  Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatment.

Authors:  Jingyao Zhang; Wenjuan Gao; Xu Yang; Jingjing Kang; Yongliang Zhang; Qirui Guo; Yanxin Hu; Guoliang Xia; Youmin Kang
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.